Treating Tracheobroncomalasia with 3D-printing at CS Mott Children's with FDA Emergency Clearance


To date, 5 children with tracheobroncomalasia have been treated at the University of Michigan CS Mott Children's Hospital with 3D-printed tracheal splints under FDA Emergency Clearance. The team, led by Dr. Scott Hollister and Dr. Glenn Green, are applying for FDA Investigational Device Exemption (IDE) to treat an additional 10 patients with this technology.

 Read more: